White label ELPA - ClinicalTrials.eu

Study of inhaled levodopa versus oral levodopa plus benserazide for early‑morning OFF in Parkinson’s disease patients

Not yet recruiting

3 1 1 1
Investigated Diseases:
- Parkinson’s disease
Investigated Drugs:
- Benserazide Hydrochloride
- Levodopa
Colchicine after Electrocardioversion to Prevent Recurrence of Atrial Fibrillation in Adult Patients

Not yet recruiting

3 1 1
Investigated Diseases:
- Atrial fibrillation
Investigated Drugs:
- Colchicine
High‑Flow Oxygen to Reduce Hypoxemia in High‑Risk Adults Undergoing Sedated Gastroscopy, Colonoscopy or Endoscopic Ultrasound

Not yet recruiting

3 1 1 1
Investigated Drugs:
- Oxygen
Low‑dose human serum albumin versus standard dose during large‑volume paracentesis in patients with liver cirrhosis

Not yet recruiting

3 1 1 1
Investigated Diseases:
- Hepatic cirrhosis
Investigated Drugs:
- Human Serum Albumin
Evaluation of Propranolol‑Enhanced Traumatic Memory Reactivation for Post‑Traumatic Stress Disorder in Women Victims of Violence

Not yet recruiting

3 1 1 1
Investigated Diseases:
- Post-traumatic stress disorder
Investigated Drugs:
- Propranolol Hydrochloride
Safety and Efficacy Study of FOXP3‑T4 and Aldesleukin in Patients with IPEX Syndrome

Not yet recruiting

1 1 1
Investigated Drugs:
- Aldesleukin
Effect of serenoa repens on chronic prostate inflammation in men with benign prostatic hyperplasia: a phase III randomized study

Not yet recruiting

3 1 1
Investigated Diseases:
- Benign prostatic hyperplasia
Efficacy and Safety of SIL204 Combined with Standard Chemotherapy in Patients with Locally Advanced Pancreatic Cancer

Not yet recruiting

4 1 1
Investigated Diseases:
- Adenocarcinoma pancreas
Efficacy of asciminib in chronic phase chronic myeloid leukemia patients with T315I mutation

Not yet recruiting

2 1 1 1
Investigated Drugs:
- Asciminib Hydrochloride
Long‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder

Not yet recruiting

3 1 1
Investigated Drugs:
- Azetukalner

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies